Zhoulong Fan

Title: **Zhoulong Fan: Innovator in PARP Inhibitor Development**

Introduction

Zhoulong Fan, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of medicinal chemistry. With a focus on developing novel compounds, he holds a patent that addresses critical health challenges.

Latest Patents

Zhoulong Fan’s patent, titled "Substituted triazolopiperazine PARP inhibitor, preparation method therefor and use thereof," introduces a class of substituted triazolopiperazine compounds. The patent encompasses various forms including tautomers, enantiomers, diastereomers, racemates, as well as their metabolites, metabolic precursors, and pharmaceutically acceptable salts, esters, prodrugs, or hydrates. This invention has potential applications in drug development for the prevention and treatment of diseases associated with PARP, including various ischemic diseases, neurodegenerative diseases, and cancers.

Career Highlights

Zhoulong Fan is affiliated with the Shanghai Institute of Materia Medica, part of the Chinese Academy of Sciences. His work is pivotal in the research and development of new pharmacological agents, particularly those aimed at combating serious diseases through targeted molecular mechanisms.

Collaborations

In his pursuit of innovation, Zhoulong collaborates with esteemed coworkers Ao Zhang and Zehong Miao. Together, they contribute to advancing scientific research and enhancing the potential therapeutic applications of their findings.

Conclusion

Zhoulong Fan is a prominent figure in the realm of pharmaceutical innovations, specifically in developing PARP inhibitors that could lead to breakthroughs in treating critical health issues. His dedication, coupled with collaborative efforts, underscores the importance of innovation in addressing complex medical challenges.